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Extracellular signal-regulated kinases (ERKs) have been implicated to be dispensable for self-
renewal of mouse embryonic stem (ES) cells, and simultaneous inhibition of both ERK signaling
and glycogen synthase kinase 3 (GSK3) not only allows mouse ES cells to self-renew independent
of extracellular stimuli but also enables more efﬁcient derivation of naïve ES cells from mouse
and rat strains. Interestingly, some ERKs stay active in mouse ES cells which are maintained in
regular medium containing leukemia inhibitory factor (LIF) and bone morphogenetic protein
(BMP). Yet, the upstream signaling for ERK activation and their roles in mouse ES cells, other than
promoting or priming differentiation, have not been determined. Here we found that mouse ES
cells express three forms of Raf kinases, A-Raf, B-Raf, and C-Raf. Knocking-down each single Raf
member failed to affect the sustained ERK activity, neither did A-Raf and B-Raf double
knockdown or B-Raf and C-Raf double knockdown change it in ES cells. Interestingly, B-Raf
and C-Raf double knockdown, not A-Raf and B-Raf knockdown, inhibited the maximal ERK
activation induced by LIF, concomitant with the slower growth of ES cells. On the other hand,
A-Raf, B-Raf, and C-Raf triple knockdown markedly inhibited both the maximal and sustained
ERK activity in ES cells. Moreover, Raf triple knockdown, similar to the treatment of U-0126, an
MEK inhibitor, signiﬁcantly inhibited the survival and proliferation of ES cells, thereby
compromising the colony propagation of mouse ES cells. In summary, our data demonstrate
that all three Raf members are required for ERK activation in mouse ES cells and are involved in
growth and survival of mouse ES cells.
& 2013 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
ERK1 and ERK2, also named as p44 MAPK and p42 MAPK,
respectively, are two well studied mitogen-activated protein
kinases (MAPKs). ERK1 and ERK2 play essential roles in a wide
variety of cellular processes, e.g. metabolism, cell migration, cell
proliferation, differentiation, and survival [12,21,31,35]. MAPK
kinase or ERK kinase (MEK) 1 and 2 phosphorylate ERK1 andC BY-NC-ND license.ERK2 at a threonine and a tyrosine residue in the kinase domain
activation loop, thereby activating them. Likewise, MAP kinase
kinase kinases (MAPKKKs) activate MEK1 and MEK2 by phos-
phorylating one or two serine sites in their activation loops of
MEKs [27]. Families of MAPKKKs include the Raf family (A-Raf,
B-Raf, and C-Raf proteins) and c-Mos kinase. The MEKK family,
including MEKK1, MEKK2, MEKK3, and MEKK4, has also been
implicated in activating the ERK signaling [8,44]. In response to
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be activated by different MAPKKKs to regulate speciﬁc cellular
events [8].
The Raf-MEK-ERK signal transduction cascade is actually one of
the best known signal cascades [7,18]. A-Raf, B-Raf, and C-Raf are
a family of protein-serine/threonine kinases that are essential for
relaying mitogenic signals to ERKs. Recently, it has been shown
that either homo- or hetero-dimerization of Rafs is required for
Raf activation [13,26]. The expression of Raf proteins exhibits both
overlapping and distinct patterns. For example, A-Raf is ubiqui-
tously expressed, but its expression levels ﬂuctuate among
different tissues [23]. Functionally, B-Raf or C-Raf knockouts are
embryonic lethal, suggesting that the Raf proteins are not
redundant, yet the cells from single knockouts show the normal
ERK activation, suggesting some redundancy among the Rafs or
the involvement of other MAPKKs [27]. Mutations of Raf genes
have been identiﬁed in some human diseases. For example, B-Raf
mutations frequently occur in melanomas, thyroid cancers, and
colorectal cancers. In addition, mutations in C-Raf or B-Raf are found
in Noonan, LEOPARD, and cardiofaciocutaneous (CFC) syndromes
[30,32]. All these data suggest that Raf family members are potential
therapeutic targets for human diseases.
Mouse embryonic stem (ES) cells are pluripotent cell lines
derived from the pre-implantation mouse embryo [10,17]. ES cells
can be expanded in culture indeﬁnitely while retaining the
capacity to produce seemingly every type of fetal and adult cell.
The pluripotent state of ES cells is controlled by the core
transcription factors, e.g. Nanog and Oct4 [6]. Self-renewal of ES
cells is achieved by a symmetric cell division concomitant with
inhibition of differentiation when maintained in the presence of
leukemia inhibitory factor (LIF) and serum or bone morphoge-
netic protein (BMP) [1]. LIF activates the transcriptional factor,
Stat3, while BMP activates another transcriptional factor, inhibitor
of differentiation (id) protein, to promote cell proliferation and
inhibit differentiation for the self-renewal of mouse ES cells [38].
ERK1 and ERK2, on the other hand, act downstream of autocrine
ﬁbroblast growth factors (FGFs) to promote cell differentiation
[3,28]. Later, it was found that self-renewal and pluripotency of ES
cells are independent of extrinsic stimuli or feeder cells by
simultaneously inhibiting ERKs and glycogen synthase kinase 3
(GSKs), indicating that ES cells have intrinsic ability to self-
replicate without differentiation [39]. The derivation of ES cells
has also been greatly facilitated by this two-inhibitor (2i) culture
condition [2,20,38]. The ground-state of mouse ES cells can also
be achieved by treatment of cells with SC1, a dual inhibitor of
ERKs and RasGAP [5]. Recently, it was found that the ground-state
pluripotency of mouse ES cells is regulated by allelic regulation of
Nanog, possibly via the FGF/ERK signaling pathway. Inhibition of
ERKs can increase the expression of Nanog through activation
of its second allele, thereby facilitating the establishment of
ground-state of ES cells [25].
Although several studies showed that ERK activation promotes
differentiation of mouse ES cells, inhibiting ERKs alone failed to
establish the true ground state of mouse ES cells. Beside ERK
inhibition, simultaneous inhibition of GSK3 [39] or activation of
PI3K-AKT signaling [5] are needed to sustain the self-renewal of
mouse ES cells. These data suggest that ERK signaling might be
also involved in other cellular process, e.g. survival or metabolism,
in mouse ES cells. Here we found that all three Raf members,
A-Raf, B-Raf, and C-Rafs, are required for ERK activation in mouseES cells and Raf triple knockdown markedly inhibited the growth
and survival of ES cells, thereby compromising the clonal propa-
gation of ES cells.Materials and methods
Reagents
A-Raf (#sc-408), B-Raf (#sc-9002), C-Raf (#sc-133), Oct4 (#sc-5279),
and Sox2 (#sc-17320) antibodies were purchased from Santa Cruz.
The phospho-ERK1/2 antibody (# 9106) was purchased from Cell
Signaling Technology. Nanog antibody (#ab80892) was purchased
from Abcam. GAPDH antibody (#G8795) was purchased from
Sigma. U0126 (#9903) was purchased from Cell Signaling Tech-
nology. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide] (#19265) was purchased from USB. TUNEL
(#G3250) assay kit was purchased from Promega. CellTrace™
CFSE Cell Proliferation Kit (#C34554) kit was purchased from
Invitrogen. Alkaline Phosphatase (AP) (#SCR004) staining kit was
purchased from Millipore.Cell culture
The mouse embryonic stem (ES) cell line D3 (from Tsang SY at
Chinese University of Hong Kong), or R1 (ATCC), or 46C (from
Austin Smith at University of Cambridge) was normally main-
tained with feeder layers of mitomycin-c treated mouse embryo-
nic ﬁbroblasts (MEFs) in Dulbecco's modiﬁed Eagle medium
(DMEM) plus 15% FBS (ES qualiﬁed, Invitrogen), 1% nonessential
amino acids (Invitrogen), 1% penicillin–streptomcyin, 0.2%
2-mercaptoethanol, and 1000 units/ml LIF. Feeder-free ES cells
were cultured on gelatin-coated plates in ES medium containing
LIF. The pluripotency of ES cells was regularly assessed by Nanog,
Oct4, and Sox2 immunostaining and alkaline phosphatase assay
according to the instruction of the manufacturer.A-Raf, B-Raf, C-Raf shRNA and scramble lentivirus
production and infection
Five optimal 21-mers were selected from the mouse A-Raf, B-Raf,
or C-Raf genes, respectively. A scramble 21-mer was selected as
control (Table S1). These sequences were then cloned into pLKO.1
vector for expressing shRNA. These shRNA plasmids were then
transfected into HEK293T cells to generate lentivirus as described
previously [42]. For infection, feeder-free ES cells were plated at a
density of 3105 cells/well in 6-well plates. On the next day, 1 ml
of shRNA lentiviruses for single knockdown was added to the cells
in fresh medium containing 8 μg/ml polybrene. For double or
triple knockdown, 2 ml or 3 ml of receptive shRNA viruses,
respectively, were concentrated via a Nanoseps 3-K sterile ﬁlter
(PALL) to 1 ml ﬁrst, and then added to the cells. 36 h later, cells
infected with shRNA lentiviruses were selected in fresh medium
containing puromycin (3 μg/ml) for 48 h. The puromycin-resistant
cells were then pooled, and the knockdown efﬁciency was
subsequently veriﬁed by western blot and qRT-PCR analyses.
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Mouse ES cells were plated at 1500 cells/well in 96-well plates,
and MTT cell proliferation assays were then performed on day 1,
2, 3, and 4 according to the manufacturer's instructions. Brieﬂy, at
each time point, 20 ml of MTT solution (5 mg/ml) for every 100 ml
medium was added to the wells and incubated for 4 h, followed
by addition of 150 mL of the DMSO solution to each well. The ﬁnal
reaction product, a purple formazan solution, was detected by
a microplate reader (Techan inﬁnite M200) for absorbance at a
wavelength of 570 nm and a reference wavelength of 630 nm.
Colony formation assay
Mouse ES cells were plated at 100 cells/well in 6-well plates in
regular ES cell medium containing LIF with feeder layers of MEFs.
After 7 days of culture, plates were rinsed with PBS, and ﬁxed
with 4% paraformaldehyde for 20 min at room temperature,
washed twice with PBS, and then colonies were imaged and
quantiﬁed using an inverted Olympus IX81 ﬂuorescence micro-
scope with a CellR image system.
Western blot analysis
Feeder free ES cells were lyzed in an ice-cold EBC lysis buffer
(50 m M HEPES at pH 7.5, 0.15 M NaCl, 1 mM EDTA, 1% NonidetFig. 1 – The effects of Erk1/2 inhibitor, U-0126, on D3 mouse ES cel
mouse ES cells. (B) U-0126 (10 μM) did not change the activity of a
markers, Oct4, Nanog, and Sox2 in mouse ES cells. Scale bar¼50 μm
ES cells as determined by MTT assay. (D) U-0126 (10 μM) inhibited
stained cells.P-40, 150 μM PMSF, 10 mM NaF, 10 ng/ml leupeptin, 1 mM DTT,
and 1 mM sodium vanadate) and passed through a 21-gauge
needle several times to disperse any large aggregates. Protein
concentrations of the cell lysates were determined by Bradford
protein assay. 50 μg of protein per lane was diluted in the
standard SDS-sample buffer and subjected to electrophoresis on
10 or 15% SDS-polyacrylamide gels. Proteins were then trans-
ferred to an Immobilon PVDF membrane (Millipore, Billerica, MA),
blocked with 5% milk in TBST (20 mM Tris, 150 mM NaCl, pH 7.6,
0.1% Tween 20) for 2 h, and incubated with the primary antibody
(1:1000 dilution) at 4 1C overnight. After washing with TBST for
three times, the blots were probed with a secondary antibody
(1:5000 dilution) for detection by chemiluminescence (Bio-RAD).
Real-time PCR
Total mRNA of mouse ES cells were extracted using a NucleoSpins
RNAII RNA extraction kit (#MNG-740955, MACHEREY-NAGEL)
according to the manufacturer's protocols. The quantitative real-
time PCR using a One Step SYBRs PrimeScript™ RT-PCR Kit II
(Perfect Real Time) (#RR086A, Takara) was performed in a
MiniOpticonTM Real-time PCR Detection System (Bio-RAD)
according to the manufacturer's instructions. The primers for
detecting A-Raf, B-Raf, C-Raf, Nanog, Oct4, Sox2 and beta-Actin
mRNAs are listed in supplemental Table S1. Relative gene expres-
sion was normalized to beta-Actin expression.ls. (A) U-0126 signiﬁcantly inhibited the activation of Erk1/2 in
lkaline phosphatase and the expression levels of pluripotency
. (C) U-0126 (10 μM) markedly inhibited proliferation of mouse
growth of ES cells as determined by FACS analysis of PI
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2.5105 feeder free ES cells were incubated in pre-warmed PBS
containing a working concentration of 10 mM CFSE for 15 min at
37 1C. Cells were then collected by centrifugation, re-suspended inFig. 2 – The effects of A-Raf, B-Raf, or C-Raf single knockdown on
knockdown had no effect on Erk1/2 activation in mouse ES cells. (B
of alkaline phosphatase and the expression of pluripotency marke
(C) A-Raf, B-Raf, or C-Raf knockdown did not change the prolifera
decreased C-Raf levels in ES cells. (E) B-Raf knockdown had no eff
immunoprecipatation complex.fresh pre-warmed ES cells medium, and incubated for another
30 min at 37 1C. Cells were subsequently collected by centrifuga-
tion and seeded into gelatin-coated 6-well plates in regular ES cell
medium. After 24 h, the cells were collected and analyzed by the
BD FACS Canto II analytic ﬂow cytometer.D3 mouse ES cells. (A) Individual A-Raf, B-Raf, or C-Raf
) A-Raf, B-Raf, or C-Raf knockdown had no effect on the activity
rs, Oct4, Nanog, and Sox2, in mouse ES cells. Scale bar¼50 μm.
tion of mouse ES cells. (D) B-Raf, not A-Raf, knockdown
ect on A-Raf levels. (F) C-Raf was present in the B-Raf
Fig. 3 – The effects of B-Raf and C-Raf or B-Raf and A-Raf double knockdown on D3 mouse ES cells. (A) and (B) A-Raf and B-Raf
double knockdown (A) or B-Raf and C-Raf double knockdown (B) failed to affect the sustained Erk activity in mouse ES cells.
(C) B-Raf and C-Raf or B-Raf and A-Raf double knockdown failed to change the activity of alkaline phosphatase and the expression
levels of pluripotency markers, Oct4, Nanog, and Sox2. Scale bar¼50 μm. (D) B-Raf and A-Raf double knockdown did not change
the proliferation of mouse ES cells. (E) B-Raf and C-Raf double knockdown inhibited proliferation of mouse ES cells as determined
by MTT assay. (F) and (G) B-Raf and C-Raf double knockdown (F), not B-Raf and A-Raf double knockdown (G), markedly inhibited
LIF-induced maxmial ERK activation in starved mouse ES cells.
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Mouse ES cells were plated at 0.7105 cells/well in gelatin-
coated cover-glass in 24-well plates in regular ES cells medium
or serum-free DMEM medium. On the next day, the apoptotic
cells were detected by TUNEL staining. In brief, cells were ﬁxed in
4% formaldehyde in PBS for 25 min at room temperature and
rinsed in PBS for twice. Cells were then incubated in 0.2%
TritonsX-100 in PBS for 5 min. After rinsing with PBS for two
times, the cells were equilibrated in 100 ml equilibration buffer at
room temperature for 10 min. 50 ml of TdT reaction mix were
added to the cells, and cells were covered with plastic cover-slips
to ensure even distribution of the mixture. After 1 h at 37 1C,
plastic coverslips were removed and cells were immersed in
2 SSC for 15 min. After rinsing three times with PBS, cells were
stained with 4′,6-diamidino-2-phenylindole (DAPI). Green ﬂuor-
escence of endonucleolytic cleavage of chromatin representing
apoptotic cells was detected by an Olympus IX81 ﬂuorescence
microscope with a CellR image system.
Immunostaining analysis
Feeder-free mouse ES cells grown on coverslips were washed with
PBS and ﬁxed with 4% paraformaldehyde for 20min at room
temperature. After the PBS washes, cells were permeabilized with
PBS containing 0.1% Triton X-100 (PBST) for 30min and blocked with
1% goat serum and 1% BSA for 1 h. Subsequently, the cells were
incubated with primary antibodies for 2 h and washed with PBST.
Secondary antibody (Alexa Fluors 488 donkey Anti-Rabbit IgG,
A21200, and Alexa Fluors568, Rabbit anti-Goat IgG, A11079, Life
Technologies, 1:1000 dilution) was then added and incubated for 1 h.
After the PBS washes, the cells were stained with DAPI. Finally, cells
were mounted with Prolong Gold Antifade Reagent (Invitrogen) on
slides. Slides were observed under an Olympus IX81 ﬂuorescence
microscope with a CCD camera to detect ﬂuorescent images.
Statistical analysis
All data were presented as mean7standard error of mean (SEM).
Student's T-test was performed to determine the differences among
grouped data. n indicates statistically signiﬁcant with Po0.05.Results
The effects of U-0126, an MEK1/2 inhibitor, on D3 mouse ES
cells
Since treatment of mouse ES cells with either PD098059, a MEK
inhibitor, or SU5402, a FGF receptor tyrosine kinase inhibitor, or
PD184352, another MEK inhibitor, alone is not enough to main-
tain the self-renewal of mouse ES cell in the absence of extra-
cellular stimuli [5,39], we ﬁrst tested the effects of U-0126 [11],
another potent MEK inhibitor, on the self-renewal of mouse ES
cells. As shown in Fig. 1A and S1A, U-0126 almost completely
abolished ERK activation when D3 mouse ES cells were main-
tained in regular medium containing LIF and grown on the feeder
cells. Similar to other MAPK inhibitors, U-0126 did not affect the
activity of alkaline phosphatase and the expression of Oct3/4,
Nanog, and Sox2 (Fig. 1B and S2), which are the common markersfor undifferentiated ES cells, indicating that the mouse ES cells
with inactive ERK signaling were undifferentiated. Notably, the
colony size of U-0126 treated ES cells was smaller than that of
control ES cells. We, thus, examined the proliferation rate of ES
cells treated with or without U-0126 in regular medium contain-
ing LIF. As shown in Fig. 1C, treatment of cells with U-0126 did
markedly inhibit the growth rate of ES cells. Similarly, cell cycle
proﬁle analysis showed that U-0126 treatment decreased the
portion of cells at S phase from 48.8% to 39%. Similar results were
also obtained in other mouse ES cell lines: R1 and 46C (Figures
S1B and S1C). Taken together, these data suggest that ERK
activation is not required for the pluripotency of mouse ES cells,
but is involved in the proliferation of cells.
The effects of A-Raf, B-Raf, or C-Raf knockdown on D3
mouse ES cells
Since all three forms of Raf proteins are expressed in mouse ES
cells [15,24], we, next, examined which Raf family member is
involved in ERK activation in ES cells. Each Raf member was
knocked-down by at least two distinctive shRNAs (Figures S3 and S4),
yet, none of the single knockdowns affected the sustained ERK
activity in mouse ES cells (Fig. 2A), suggesting the redundancy of
Raf members in ERK activation in ES cells. Not surprisingly, each
Raf single knockdown had no effect on the activity of alkaline
phosphatase and the expression of Oct3/4, Nanog, and Sox2
in mouse ES cells (Fig. 2B and S2), indicating that A-Raf,
B-Raf, or C-Raf is not required for stemness of ES cells. Also, Raf
single knockdown did not change the proliferation of ES cells
(Fig. 2C). Interestingly, we found that B-Raf knockdown also
decreased the levels of C-Raf, not A-Raf (Fig. 2D), in ES cells, yet
A-Raf knockdown did not affect C-Raf levels (Fig. 2E). Since B-Raf
and C-Raf formed complexes in ES cells (Fig. 2F), we speculate
that B-Raf knockdown might result in the instability of C-Raf, yet
the underlying mechanism remains to be determined.
The effects of B-Raf and C-Raf or B-Raf and A-Raf double
knockdown on mouse ES cells
We have previously shown that B-Raf and C-Raf are required for
Ras-stimulated p42 MAP kinase activation in Xenopus egg extracts
[43]. Therefore, it was of interest to determine whether ERK
activation in mouse ES cells also requires both B-Raf and C-Raf.
Unexpectedly, B-Raf and C-Raf double knockdown (Fig. S4) failed
to change the sustained ERK activity in mouse ES cells maintained
in regular medium containing LIF (Fig. 3A). Similarly, B-Raf and
A-Raf double knockdown (Fig. S4) also had no effect on ERK activity
in ES cells maintained in regular medium plus LIF (Fig. 3B).
In addition, neither B-Raf and C-Raf double knockdown nor A-Raf
and B-Raf double knockdown changed activity of alkaline phos-
phatase and the expression of Oct3/4, NANOG, and Sox2 in mouse
ES cells (Fig. 3C and S2). Interestingly, although A-Raf and B-Raf
double knockdown failed to affect the proliferation of ES cells
(Fig. 3D), B-Raf and C-Raf double knockdown markedly inhibited
it (Fig. 3E). LIF or serum actually activated ERKs in a time-
dependent manner in starved mouse ES cells: peaking around
15–30 min, thereafter some ERKs staying active (Fig. S5 and data
not shown). Therefore, we subsequently examined whether
LIF-induced ERK activation was affected by these Raf double
knockdown. Indeed, B-Raf and C-Raf, not A-Raf and B-Raf, double
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vation in starved ES cells, yet neither double knockdown affected
the sustained ERK activity (Fig. 3F and G). Taken together, ourFig. 4 – The effects of A-Raf, B-Raf, and C-Raf triple knockdown on D
inhibited Erk1/2 activation in mouse ES cells. (B) A-Raf, B-Raf, and C
starved mouse ES cells. (C) A-Raf, B-Raf, and C-Raf tripe knockdow
pluripotency of mouse ES cells. Scale bar¼50 μm. (D) A-Raf, B-Raf
proliferation of mouse ES cells as determined by MTT assay.results indicate that both B-Raf and C-Raf, not A-Raf, are required
for the maximal ERK activation in mouse ES cells, even though
A-Raf, B-Raf, or C-Raf is redundant in maintaining the sustained3 mouse ES cells. (A) A-Raf, B-Raf, and C-Raf triple knockdown
-Raf triple knockdown abolished LIF-induced ERK activation in
n had no effect on the activity of alkaline phosphatase and the
, and C-Raf triple knockdown markedly compromised the
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yet transient, ERK activation is involved in the proliferation of
ES cells.
The effects of A-Raf, B-Raf, and C-Raf triple knockdown on
mouse ES cells
Next, we examined whether all three Raf members are required
for the sustained ERK activity in mouse ES cells maintained in
regular ES medium containing LIF. Therefore, we knocked-down
all three Raf members in mouse ES cells (Fig. S4) and found that
A-Raf, B-Raf, and C-Raf triple knockdown indeed markedly
decreased the sustained ERK activity in ES cells (Fig. 4A).
We speculated that the residual ERK activity in triple Raf knockdown
cells might be due to the remaining Raf proteins resistant to
shRNAs. Moreover, the ability of LIF to activate ERKs in starved ES
cells was almost abolished by Raf triple knockdown, which was
similar to that in ES cells treated with U-0126 (Fig. 4B). These data
indicated that all three Raf members are required for ERKs
activation in mouse ES cells. As expected, the Raf triple knock-
down also failed to change the activity of alkaline phosphatase
and the expression of Oct3/4, NANOG, and Sox2 in mouse ES cells
(Fig. 4C and S2), again echoing that the stemness of ES cells is
independent of the Raf/ERK signaling. Notably, the colony size of
Raf triple knockdown ES cells is smaller than that of control ES
cells (Fig. 4C), which is conspicuously similar to that of U-0126
treated cells (Fig. 1B). Not surprisingly, Raf triple knockdownmarkedly
inhibited the proliferation of ES cells (Fig. 4D). In summary, these data
indicate that all three Raf members are required for both maximal
and sustained ERK activity in ES cells and are involved in the
proliferation of mouse ES cells.Fig. 5 – The role of Raf/ERK signaling on the colony propagation of
knockdown, B-Raf and C-Raf double knockdown, A-Raf, B-Raf, an
colonies. Scale bar¼100 μm. (B) The sizes of control, B-Raf knockd
C-Raf triple knockdown, and U-0126 (10 μM) treated ES cell colon
knockdown, B-Raf and C-Raf double knockdown, A-Raf, B-Raf, andRoles of the Raf/ERK signaling on colony propagation
of mouse ES cells
One key characteristic of the mouse ES cells is its ability to
propagate from a single cell to form a colony [9]. Since treatment
of cells with U-0126 or Raf triple knockdown markedly inhibited
cell proliferation, we assessed the role of Raf/ERK signaling in
colony propagation of mouse ES cells. We plated the ES cells at
single cell density, and analyzed the colony size and number after
seven days. As shown in Fig. 5A and B, single B-Raf knockdown
had no effects on colony size of ES cells, which was consistent
with the fact that B-Raf knockdown failed to affect ES cell
proliferation (Fig. 2C). On the other hand, B-Raf and C-Raf double
knockdown, or Raf triple knockdown, or U-0126 treatment
markedly decreased the colony size (Fig. 5A and B). Moreover,
the Raf triple or double Raf knockdown, like U-0126 treatment,
signiﬁcantly inhibited the ability of mouse ES cells to form a
colony from a single cell (Fig. 5C). Taken together, these data
document that the Raf/ERK signaling is required for colony
propagation of mouse ES cells.
The role of the Raf/ERK signaling on cell division
and survival of mouse ES cells
The smaller colony size of Raf triple knockdown mouse ES cells is
possibly due to either slower cell proliferation rate (or longer time
to ﬁnish one cell division cycle) or increased cell death. We, thus,
ﬁrst assessed whether Raf triple knockdown slows down the cell
division rate of mouse ES cells. To do so, cells were pulsed with
carboxyﬂuorescein succinimidyl ester (CFSE) for 15 min [14]. Once
inside cells, the colorless CFSE covalently reacts with intracellularD3 mouse ES cells. (A) Representative images of control, B-Raf
d C-Raf triple knockdown, and U-0126 (10 μM) treated ES cell
own, B-Raf and C-Raf double knockdown, A-Raf, B-Raf, and
ies. (C) The efﬁciency of colony formation in control, B-Raf
C-Raf triple knockdown, and U-0126 (10 μM) treated ES cells.
Fig. 6 – The role of the Raf/ERK signaling on cell division and survival of D3 mouse ES cells. (A) A-Raf, B-Raf, and C-Raf triple
knockdown signiﬁcantly slowed the cell division of mouse ES cells as determined by FACS analysis of CFSE pulsed ES cells.
(B) A-Raf, B-Raf, and C-Raf triple knockdown, and U-0126 (10 μM) treatment markedly induced apoptosis in mouse ES cells
as determined by TUNEL assay. Scale bar¼25 μm.
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divides, its daughter cells only inherit half of the ﬂuorescence-
labeled molecule, thus each cell division cycle can be assessed by
the corresponding decrease of cell ﬂuorescence. As shown in
Fig. 6A, control ES cells divided three times in 24 h, but the cell
number for the seceond and third cell division in Raf triple
knockdown cells was much less than that of control ES cells.
These data indicate that Raf/ERK signaling indeed regulates
proliferation of ES cells. Subsequently, we examined whether
the smaller colony size of ES cells might also be due to decreasedcell survival induced by inhibition of Raf/ERK signaling. A TUNEL
assay showed that more Rafs triple knockdown or U-126 treated
cells underwent programmed cell death when cells were plated at
single cell density (Fig. 6B). We also reasoned that the cells inside
a colony might be starved because of limited access of serum and
LIF. We thus performed a TUNEL assay on starved ES cells as well,
and found starvation markedly induced apoptotic cells and
treatment of cells with U-0126 treatment or Raf triple knockdown
further induced it. These data suggest that inhibiting Raf/ERK
signaling compromises survival of mouse ES cells. In summary,
E X P E R I M E N T A L C E L L R E S E A R C H 3 1 9 ( 2 0 1 3 ) 2 8 0 1 – 2 8 1 12810these data demonstrate that the Raf/ERK signaling is required
both growth and survival of mouse ES cells.Discussion
Here we reported that all three Raf family members, A-Raf, B-Raf,
and C-Raf, were required for ERK activation in mouse ES cells
(Fig. 4A and B). Yet, A-Raf, B-Raf, and C-Raf triple knockdown had
no effects on the expression of Oct4, Nanog, or Sox2 in ES cells
(Fig. 4C and S2), which are three master regulators for pluripo-
tency [4,16,29]. In addition, the activity of alkaline phosphatase in
mouse ES cells was not affected by Raf triple knockdown (Fig. 4C).
These data indicate that the Raf knockdown mouse ES cells are
undifferentiated, which echoes the previous ﬁndings that one of
the main roles of ERK signaling in mouse ES cells is to promote
rather than inhibiting differentiation [3,19]. However, we also
found that Raf triple knockdown or treatment with a MEK1/2
inhibitor compromised the colonal propogation of mouse ES cells
(Fig. 5). The decreased ability of Raf triple knockdown ES cells to
propagate from a single cell is the result of the combined effects
of reduced cell proliferation and survival of ES cells (Fig. 6).
In summary, these data suggest that the Raf/ERK signaling plays a
dichotomic role in mouse ES cells, in that it promotes or primes ES
cells for differentiation [3,19]; on the other hand, it is required for
the growth and survival of ES cells.
It has been well established that ERK activation promotes or
primes mouse ES cells for differentiation [3,19]. Inhibiting ERK
signaling with either co-inhibition of GSK3 or co-activation of
PI3K signaling pushes mouse ES cells into a naïve ground state of
self-renewal [5,39]. But it was also found that inhibiting ERK
alone could not lead ES cells into the ground state, as the ground
state of ES cells needed to be maintained by simutanously
inhibiting ERK and GSK3 or RasGAP [5,39]. Here our data
demonstrated that Raf/ERK signaling is also required for the
growth and survival of mouse ES cells (Figs. 5 and 6). These data
suggest that Raf/ERK inhibition could result in the growth and
survival defects of mouse ES cells, which can be compensated for
by inhibiting GSK3 or activating PI3K in order to maintain the
ground state of self-renewal of ES cells. Interestingly, it has been
previously shown that inhibiting ERK signaling in human ES cells
by either speciﬁc MEK inhibitors or by RNA interference, com-
promised the self-renewal of cells [22,36]. Yet, human ES cells and
mouse ES cells represent distinctive developmental stages, a post-
implantation state versus a naïve pre-implantation state, respec-
tively [1].
Notably, LIF or FBS actually quickly activated ERKs in starved
mouse ES cells, which peaked around 15–30 min; thereafter most
of them became inactivated with some staying active (Figs. 3F, 4B,
S3, and data not shown). It has also been well documented that
EGF can transiently activate ERK to promote the proliferation of
PC12 cells, whereas NGF can result in a sustained ERK activation
to induce the neural differentiation of PC12 cells [33,34,37].
Accordingly, it is possible that the early activated ERKs at mamixal
levels in mouse ES cells are functioning to promote cell prolifera-
tion and survival, whereas the late sustained ERK activity might
be responsible for promoting or priming ES cells for differentia-
tion. Indeed, we found that B-Raf and C-Raf, not A-Raf and B-Raf,
double knockdown failed to affect the sustained ERK activation
but markedly inhibited the maximal ERK activation by LIF orserum (Fig. 3F and G). Consistently, B-Raf and C-Raf, not A-Raf and
B-Raf, double knockdown inhibited the proliferation of mouse ES
cells (Fig. 3C), suggesting that maximal ERK activation might be
required for cell growth.
Multiple MAPKKKs can acitivate ERK signaling in response to
different upstream stimuli. For example, in Xenopus egg extract,
active Cdc2-cyclin B can ultilize c-Mos to active ERK2 dutring
mitosis [40,41], whereas oncogenic Ras proteins activate B-Raf
and C-Raf, but not c-Mos, for MEK1 and p42 MAPK activation [43].
Similarly, LIF or endocrine FGFs activates Ras to stimulate Raf/
MEK/ERKs signaling in mouse ES cells [3,5]. Here we found that
all three forms of Raf proteins are involved in sustained ERK
activation, suggesting the redundancy of Raf proteins to some
extent. Yet, we also found that A-Raf is only involved in the
maximal, but not the sustained, ERK activation, whereas B-Raf
and C-Raf are required for both (Figs. 3 and 4). Thus these data
show the distinct role of Raf members in ERK activation. Also
notably, triple Raf knockdown failed to completely abolish ERK
activity in mouse ES cells (Fig. 4A), which might be due to the
remaining Raf proteins resistant to shRNAs, or other MAPKKKs,
such as c-Mos, or both. Yet c-Mos was not detected in mouse ES
cells (data not shown).
Here our data showed that Raf triple knockdown compromised
the growth and survival of mouse ES cells, concomitant with the
inhibition of ERK activity, suggesting that Raf kinases activate ERK
signaling for these processes. Yet, other than activating ERK
signaling, Raf members can act independent of ERK signaling to
regulate some cellular processes, e.g. apoptosis. In addition, Raf
kinases can function as scaffold proteins independent of their
kinase activity [15,24]. Therefore, it is of interest to determine
whether expressing an active form of ERK or MEK protein in Raf
triple knockdown cells rescues the defects in mouse ES cells.Acknowledgment
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